LncRNA Research: Functions, Experimental Strategies, and Plasmid Applications
LncRNA Research: Functions, Experimental Strategies, and Plasmid Applications
Introduction to lncRNAs
Research on long non-coding RNAs (lncRNAs) in cancer has advanced rapidly in recent years. Increasing evidence suggests that lncRNA dysregulation or mutations are closely associated with cancer development and progression. Researchers are investigating these relationships from multiple perspectives to better understand the mechanisms underlying cancer and identify potential biomarkers and therapeutic targets.
1. Characteristics of lncRNAs
Length: lncRNAs are generally defined as non-coding RNAs longer than 200 nucleotides. Some lncRNAs contain a poly(A) tail.
Limited protein-coding capacity: Some lncRNAs can associate with ribosomes, but most have little or no protein-coding capacity.
Lower sequence conservation: Compared with mRNAs, lncRNAs generally show lower levels of evolutionary conservation.
Tissue- and time-specific expression: lncRNA expression can be highly tissue-specific and may vary depending on developmental stage, cellular state, or other biological conditions.
2. Functions of lncRNAs
lncRNAs can fold into diverse three-dimensional structures and interact with a wide range of proteins. They can also recognize other nucleic acids through complementary base pairing. Through these interactions, lncRNAs can recruit regulatory proteins to specific genomic or RNA sequences, enabling them to participate in diverse biological processes, including development and cancer progression.
lncRNAs can regulate gene expression at multiple levels, including epigenetic, transcriptional, and post-transcriptional regulation.
Common mechanisms include:
Interaction with transcription factors: lncRNAs can bind transcription factors and interfere with or facilitate their recruitment to promoters, thereby regulating transcription.
Interaction with miRNAs: Some lncRNAs can bind miRNAs and reduce their availability for interaction with target mRNAs, thereby influencing mRNA stability or translation.
Scaffolding for protein interactions: lncRNAs can serve as molecular scaffolds that bring multiple proteins together, affecting protein complex formation and protein activity.
Interaction with mRNAs: lncRNAs can base-pair with mRNAs and influence their stability, localization, translation, or degradation.
3. How to Find lncRNA Sequences
The NCBI database can be used to identify the sequence of a target lncRNA.
A general workflow is:
NCBI → Gene → Enter the gene name → Search → Select the appropriate species → Open the corresponding gene record → Locate the relevant RefSeq transcript (NR accession)
The corresponding NR accession sequence can then be used as a reference for obtaining the lncRNA transcript sequence.
When designing experiments, it is important to confirm the transcript accession, isoform, species, and sequence annotation before proceeding with plasmid construction.
4. Plasmid Construction and Experimental Strategies for lncRNA Research
(1) lncRNA Overexpression
① Conventional Eukaryotic Expression Vectors
A conventional mammalian expression vector can be used to express an lncRNA, such as p0157/pcDNA3.1(+) or p23835/pEnCMV-EGFP-Linker-MCS.
The target lncRNA sequence can be cloned into the selected expression vector and introduced into mammalian cells, such as human 293T cells. Depending on the vector and experimental design, antibiotic selection and subsequent expansion can be used to establish a stable cell population.
Total RNA can then be isolated from the resulting cells, reverse-transcribed into cDNA, and analyzed by real-time quantitative PCR (RT-qPCR) to determine the relative expression level of the target lncRNA.
② Lentiviral Expression Vectors
Lentiviral expression vectors can be used when efficient delivery or stable expression is required.
Examples include:
Common lentiviral packaging plasmids include:
The target lncRNA sequence is cloned into the selected lentiviral expression vector and introduced into packaging cells together with the appropriate packaging plasmids. After viral production, the resulting lentiviral preparation can be evaluated using an appropriate viral titering method.
If the vector contains a fluorescent reporter, such as GFP, fluorescence can be used as an indicator of transduction efficiency. Antibiotic selection can subsequently be used to enrich for stably transduced cells, followed by RT-qPCR to assess lncRNA expression.
(2) Subcellular Localization of lncRNAs
Determining the subcellular localization of an lncRNA can provide important clues about its potential mechanism of action.
Fluorescent protein expression vectors, such as p0134/pEGFP-C1 and p0151/pmCherry-C1, can be used when an appropriate fusion-based experimental design is applicable.
However, because lncRNAs are RNA molecules rather than proteins, fluorescence in situ hybridization (FISH) is commonly used to directly determine their subcellular localization.
FISH can distinguish whether an lncRNA is predominantly localized in the nucleus, cytoplasm, or other subcellular compartments, providing useful information for subsequent functional studies.
(3) lncRNA Knockdown
Lentiviral RNAi vectors can be used to investigate the biological functions of lncRNAs through knockdown experiments.
Examples include:
Common packaging plasmids include:
Potential RNAi target sequences can be designed based on the target lncRNA transcript sequence obtained from databases such as NCBI. The selected target sequence is then incorporated into an appropriate RNAi vector for subsequent delivery and functional analysis.
The localization of the lncRNA should be considered when selecting an appropriate knockdown strategy. RNAi-mediated knockdown is generally more effective for cytoplasmic RNA targets, whereas nuclear lncRNAs may require alternative approaches, such as antisense oligonucleotides (ASOs) or other nuclear RNA-targeting strategies.
Therefore, determining lncRNA localization before selecting the knockdown method can help improve experimental design.
(4) Investigating lncRNA–miRNA Interactions
Potential interactions between a target lncRNA and miRNA can initially be predicted using online bioinformatics tools.
Candidate binding sites can then be experimentally validated using a dual-luciferase reporter assay.
A common strategy is to clone the candidate lncRNA binding sequence downstream of the luciferase reporter in a vector such as pmirGLO. A corresponding mutant reporter can also be constructed by introducing mutations into the predicted miRNA-binding site.
The reporter plasmids can be co-transfected into cells, such as human 293T cells, together with:
miRNA mimics, which increase the intracellular activity of the target miRNA;
Negative-control mimics, which serve as experimental controls.
Depending on the experimental design, miRNA inhibitors can also be used to suppress endogenous miRNA activity.
Appropriate controls should include a reporter containing the wild-type target sequence, a reporter containing the mutated target sequence, and suitable miRNA negative controls.
Changes in luciferase activity can then be used to determine whether the predicted miRNA-binding site mediates a functional interaction.
(5) Investigating lncRNA–Protein Interactions
Potential lncRNA-binding proteins can be identified through bioinformatics prediction, published literature, or high-throughput sequencing and other omics datasets.
For example, differential expression data from transcriptomic studies can be analyzed to identify genes or proteins potentially associated with the biological function of the target lncRNA.
Based on these results, appropriate overexpression or knockdown constructs can be generated for functional validation.
Several experimental approaches can be used to investigate lncRNA–protein interactions.
RNA Pull-Down
RNA pull-down can be used when the lncRNA is known but its interacting proteins are unknown or need to be identified.
A labeled lncRNA probe and an appropriate control RNA can be incubated with cell lysates. RNA–protein complexes can then be captured using affinity beads, such as streptavidin-coated magnetic beads when a biotin-labeled RNA probe is used.
The enriched proteins can be separated by SDS-PAGE. Specific protein bands can subsequently be identified by mass spectrometry.
If a candidate protein is already known, the enriched material can also be analyzed using techniques such as Western blotting.
RNA Immunoprecipitation (RIP)
RIP can be used when a candidate RNA-binding protein is known and the goal is to determine whether it associates with the target lncRNA.
An antibody against the candidate RNA-binding protein is used to immunoprecipitate the associated RNA–protein complexes. An isotype-matched IgG antibody is typically included as a negative control.
The co-precipitated RNA can then be analyzed by RT-qPCR to determine whether the target lncRNA is enriched in the immunoprecipitated fraction.
Electrophoretic Mobility Shift Assay (EMSA)
EMSA can be used to investigate direct or specific interactions between a candidate RNA-binding protein and an RNA probe.
A labeled RNA probe is incubated with the candidate protein. Formation of an RNA–protein complex can alter the migration of the RNA probe during electrophoresis under appropriate non-denaturing conditions.
A mobility shift can provide evidence for RNA–protein binding, while competition and other appropriate controls can help evaluate binding specificity.
Once an interaction has been established, downstream signaling pathways can be investigated by examining the expression or activation of additional proteins. This can help determine whether lncRNA–protein interactions contribute to broader regulatory effects.
(6) Validating the Protein-Coding Potential of an lncRNA
Although lncRNAs are generally classified as non-coding RNAs, some transcripts may contain short open reading frames (sORFs) capable of producing functional micropeptides.
To investigate potential coding activity, a candidate coding region can be fused to an appropriate epitope tag, such as FLAG, and expressed using a suitable vector.
Protein expression can then be evaluated using methods such as Western blotting or immunodetection.
Detection of a translated peptide provides evidence supporting the coding potential of the tested sequence. Additional experiments are generally required to establish whether the encoded peptide is biologically functional.
(7) Other Functional Studies
The relationship between lncRNAs and mRNAs can also be investigated through gain-of-function and loss-of-function experiments.
For example, lncRNA overexpression or knockdown can be combined with cellular phenotypic assays to investigate effects on:
Cancer cell proliferation
Apoptosis
Cell migration
Cell invasion
Cell-cycle progression
Combining molecular studies with cellular phenotyping can help clarify the biological role of a specific lncRNA and identify potential molecular mechanisms and therapeutic targets relevant to disease research.
Summary
lncRNAs participate in gene regulation through diverse mechanisms involving DNA, RNA, and protein interactions. Their functions can be investigated using a combination of sequence analysis, expression manipulation, subcellular localization, RNA interference, luciferase reporter assays, RNA pull-down, RIP, EMSA, and cellular functional assays.
An integrated experimental strategy that combines molecular mechanism studies with cellular phenotyping can provide a more comprehensive understanding of lncRNA function and its potential role in disease.
